Display Settings:

Format

Send to:

Choose Destination
    Am J Cardiol. 1998 Jan 15;81(2):238-40.

    Torsades de Pointes associated with intravenous haloperidol in critically ill patients.

    Source

    Department of Internal Medicine, Henry Ford Hospital, and the College of Pharmacy, Wayne State University, Detroit, Michigan 48202, USA.

    Abstract

    In this retrospective case-control study, 8 of 223 consecutive patients (3.6%) treated with intravenous haloperidol developed torsades de pointes, and were compared with 41 patients randomly selected as controls. The likelihood of torsades de pointes associated with intravenous haloperidol is significantly greater in patients receiving > or = 35 mg over 24 hours or in those with a QTc interval of >500 ms, or both.

    PMID:
    9591913
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk